Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 2
1956 1
1957 1
1959 3
1960 3
1961 5
1962 9
1963 11
1964 7
1965 10
1966 4
1967 6
1968 5
1969 5
1970 7
1971 6
1972 2
1973 11
1974 5
1975 11
1976 9
1977 7
1978 4
1979 4
1980 8
1981 9
1982 5
1983 10
1984 12
1985 6
1986 13
1987 5
1988 11
1989 8
1990 11
1991 11
1992 6
1993 8
1994 9
1995 14
1996 15
1997 10
1998 19
1999 18
2000 20
2001 14
2002 10
2003 30
2004 28
2005 25
2006 24
2007 24
2008 30
2009 25
2010 27
2011 17
2012 21
2013 19
2014 26
2015 27
2016 25
2017 16
2018 24
2019 34
2020 26
2021 34
2022 27
2023 20
2024 18
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

895 results

Results by year

Filters applied: . Clear all
Page 1
Dupuytren's Disease-Etiology and Treatment.
Ruettermann M, Hermann RM, Khatib-Chahidi K, Werker PMN. Ruettermann M, et al. Among authors: hermann rm. Dtsch Arztebl Int. 2021 Nov 19;118(46):781-788. doi: 10.3238/arztebl.m2021.0325. Dtsch Arztebl Int. 2021. PMID: 34702442 Free PMC article. Review.
Hereditary haemorrhagic telangiectasia.
Hermann R, Shovlin CL, Kasthuri RS, Serra M, Eker OF, Bailly S, Buscarini E, Dupuis-Girod S. Hermann R, et al. Nat Rev Dis Primers. 2025 Jan 9;11(1):1. doi: 10.1038/s41572-024-00585-z. Nat Rev Dis Primers. 2025. PMID: 39788978 Review.
G-quadruplex DNA structure is a positive regulator of MYC transcription.
Esain-Garcia I, Kirchner A, Melidis L, Tavares RCA, Dhir S, Simeone A, Yu Z, Madden SK, Hermann R, Tannahill D, Balasubramanian S. Esain-Garcia I, et al. Among authors: hermann r. Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2320240121. doi: 10.1073/pnas.2320240121. Epub 2024 Feb 5. Proc Natl Acad Sci U S A. 2024. PMID: 38315865 Free PMC article.
PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Patel JD, Socinski MA, Garon EB, Reynolds CH, Spigel DR, Olsen MR, Hermann RC, Jotte RM, Beck T, Richards DA, Guba SC, Liu J, Frimodt-Moller B, John WJ, Obasaju CK, Pennella EJ, Bonomi P, Govindan R. Patel JD, et al. Among authors: hermann rc. J Clin Oncol. 2013 Dec 1;31(34):4349-57. doi: 10.1200/JCO.2012.47.9626. Epub 2013 Oct 21. J Clin Oncol. 2013. PMID: 24145346 Free PMC article. Clinical Trial.
DEGRO 2004 : 10. Jahreskongress der Deutschen Gesellschaft für Radioonkologie.
Wendt TG, Gademann G, Pambor C, Grießbach I, von Specht H, Martin T, Baltas D, Kurek R, Röddiger S, Tunn UW, Zamboglou N, Eich HT, Staar S, Gossmann A, Hansemann K, Semrau R, Skripnitchenko R, Diehl V, Müller RP, Sehlen S, Willich N, Rühl U, Lukas P, Dühmke E, Engel K, Tabbert E, Bolck M, Knaack S, Annweiler H, Krempien R, Hoppe H, Harms W, Daeuber S, Schorr O, Treiber M, Debus J, Alber M, Paulsen F, Birkner M, Bakai A, Belka C, Budach W, Grosser KH, Kramer R, Kober B, Reinert M, Schneider P, Hertel A, Feldmann H, Csere P, Hoinkis C, Rothe G, Zahn P, Alheit H, Cavanaugh SX, Kupelian P, Reddy C, Pollock B, Fuss M, Roeddiger S, Dannenberg T, Rogge B, Drechsler D, Herrmann T, Alberti W, Schwarz R, Graefen M, Krüll A, Rudat V, Huland H, Fehr C, Baum C, Glocker S, Nüsslin F, Heil T, Lemnitzer H, Knips M, Baumgart O, Thiem W, Kloetzer KH, Hoffmann L, Neu B, Hültenschmidt B, Sautter-Bihl ML, Micke O, Seegenschmiedt MH, Köppen D, Klautke G, Fietkau R, Schultze J, Schlichting G, Koltze H, Kimmig B, Glatzel M, Fröhlich D, Bäsecke S, Krauß A, Strauß D, Buth KJ, Böhme R, Oehler W, Bottke D, Keilholz U, Heufelder K, Wiegel T, Hinkelbein W, Rödel C, Papadopoulos T, Munnes M, Wirtz R, Sauer R, R… See abstract for full author list ➔ Wendt TG, et al. Among authors: hermann rm. Strahlenther Onkol. 2004 Jun;180 Suppl 1:5-87. doi: 10.1007/BF03356734. Strahlenther Onkol. 2004. PMID: 27137922 German. No abstract available.
Letter to the editor.
Hermann RM, Nitsche M. Hermann RM, et al. Br J Radiol. 2023 Oct 1;96(1150):20210884. doi: 10.1259/bjr.20210884. Epub 2021 Dec 17. Br J Radiol. 2023. PMID: 34919447 Free PMC article. No abstract available.
Merkel cell carcinoma.
Nyrud MK, Bratland Å, Landrø L, Brevig T, Ryder T, Hermann R, Frich L. Nyrud MK, et al. Among authors: hermann r. Tidsskr Nor Laegeforen. 2022 Jun 13;142(9). doi: 10.4045/tidsskr.21.0693. Print 2022 Jun 14. Tidsskr Nor Laegeforen. 2022. PMID: 35699540 Free article. English, Norwegian.
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Dupuis-Girod S, Rivière S, Lavigne C, Fargeton AE, Gilbert-Dussardier B, Grobost V, Leguy-Seguin V, Maillard H, Mohamed S, Decullier E, Roux A, Bernard L, Saurin JC, Saroul N, Faure F, Cartier C, Altwegg R, Laccourreye L, Oberti F, Beaudoin M, Dhelens C, Desvignes C, Azzopardi N, Paintaud G, Hermann R, Chinet T. Dupuis-Girod S, et al. Among authors: hermann r. J Intern Med. 2023 Dec;294(6):761-774. doi: 10.1111/joim.13714. Epub 2023 Aug 23. J Intern Med. 2023. PMID: 37592715 Clinical Trial.
895 results